NF-κB-Mediated HER2 Overexpression in Radiation-Adaptive Resistance
- Purdue Univ., West Lafayette, IN (United States)
- Emory Univ., Atlanta, GA (United States)
- Indiana University School of Medicine, Indianapolis IN (United States)
The molecular mechanisms governing acquired tumor resistance during radiotherapy remain to be elucidated, In breast cancer patients, overexpression of HER2 (human epidermal growth factor receptor 2) is correlated with aggressive tumor growth and increased recurrence. In the present study, we demonstrate that HER2 expression can be induced by radiation in breast cancer cells with a low basal level of HER2. Furthermore, HER2-postive tumors occur at a much higher frequency in recurrent invasive breast cancer (59%) compared to the primary tumors (41%). Interestingly, NF-κB is required for radiation-induced HER2 transactivation. HER2 was found to be co-activated with basal and radiation-induced NF-κB activity in radioresistant but not radiosensitive breast cancer cell lines after long-term radiation exposure, indicating that NF-κB-mediated HER2 overexpression is involved in radiation-induced repopulation in heterogeneous tumors. Finally, we found that inhibition of HER2 resensitizes the resistant cell lines to radiation. Since HER2 is shown to activate NF-κB, our data suggest a loop-like HER2-NF-κB-HER2 pathway in radiation-induced adaptive resistance in breast cancer cells.
- Research Organization:
- Purdue Univ., West Lafayette, IN (United States)
- Sponsoring Organization:
- USDOE Office of Science (SC), Biological and Environmental Research (BER)
- DOE Contract Number:
- FG02-05ER63945;
- OSTI ID:
- 1054350
- Report Number(s):
- DE-FG02--05ER63945; 101828
- Country of Publication:
- United States
- Language:
- English
Similar Records
NF-κB and neutrophil extracellular traps cooperate to promote breast cancer progression and metastasis
Lapatinib in Combination With Radiation Diminishes Tumor Regrowth in HER2+ and Basal-Like/EGFR+ Breast Tumor Xenografts
Heregulin-induced cell migration is promoted by aryl hydrocarbon receptor in HER2-overexpressing breast cancer cells
Journal Article
·
Sun Aug 15 00:00:00 EDT 2021
· Experimental Cell Research
·
OSTI ID:23195575
Lapatinib in Combination With Radiation Diminishes Tumor Regrowth in HER2+ and Basal-Like/EGFR+ Breast Tumor Xenografts
Journal Article
·
Tue Jun 01 00:00:00 EDT 2010
· International Journal of Radiation Oncology, Biology and Physics
·
OSTI ID:21372311
Heregulin-induced cell migration is promoted by aryl hydrocarbon receptor in HER2-overexpressing breast cancer cells
Journal Article
·
Tue May 15 00:00:00 EDT 2018
· Experimental Cell Research
·
OSTI ID:23082402